Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pratima Nangia-Makker

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 8, 2012
Galectin-3 binding and metastasisPratima Nangia-Makker, Vitaly Balan, Avraham Raz
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|March 25, 2009
Regulation of tumor progression by extracellular galectin-3Pratima Nangia-Makker, Vitaly Balan, Avraham Raz
Cancers|May 10, 2013
Galectins as cancer biomarkersVitaly Balan, Pratima Nangia-Makker, Avraham Raz
Glycobiology|August 21, 2014
Galectin-3 in angiogenesis and metastasisTatsuyoshi Funasaka, Avraham Raz, Pratima Nangia-Makker
Seminars in Cancer Biology|March 25, 2014
Nuclear transport of galectin-3 and its therapeutic implicationsTatsuyoshi Funasaka, Avraham Raz, Pratima Nangia-Makker
Glycobiology|January 10, 2018
Galectin-3 and cancer stemnessPratima Nangia-Makker, Victor Hogan, Avraham Raz
World Journal of Gastrointestinal Pathophysiology|November 25, 2015
Role of cancer stem cells in age-related rise in colorectal cancerPratima Nangia-Makker, Yingjie Yu, Adhip Pn Majumdar
Trends in Molecular Medicine|April 3, 2002
Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agentsPratima Nangia-Makker, Jeffrey Conklin, Victor Hogan, et al.
Journal of Bioenergetics and Biomembranes|February 24, 2007
Galectin-3 in apoptosis, a novel therapeutic targetPratima Nangia-Makker, Susumu Nakahara, Victor Hogan, et al.
The Journal of Biological Chemistry|October 22, 2022
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseasesPratima Nangia-Makker, Victor Hogan, Vitaly Balan, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|June 8, 2012
Galectin-3 binding and metastasisPratima Nangia-Makker, Vitaly Balan, Avraham Raz
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|March 25, 2009
Regulation of tumor progression by extracellular galectin-3Pratima Nangia-Makker, Vitaly Balan, Avraham Raz
Cancers|May 10, 2013
Galectins as cancer biomarkersVitaly Balan, Pratima Nangia-Makker, Avraham Raz
Glycobiology|August 21, 2014
Galectin-3 in angiogenesis and metastasisTatsuyoshi Funasaka, Avraham Raz, Pratima Nangia-Makker
Seminars in Cancer Biology|March 25, 2014
Nuclear transport of galectin-3 and its therapeutic implicationsTatsuyoshi Funasaka, Avraham Raz, Pratima Nangia-Makker
Glycobiology|January 10, 2018
Galectin-3 and cancer stemnessPratima Nangia-Makker, Victor Hogan, Avraham Raz
World Journal of Gastrointestinal Pathophysiology|November 25, 2015
Role of cancer stem cells in age-related rise in colorectal cancerPratima Nangia-Makker, Yingjie Yu, Adhip Pn Majumdar
Trends in Molecular Medicine|April 3, 2002
Carbohydrate-binding proteins in cancer, and their ligands as therapeutic agentsPratima Nangia-Makker, Jeffrey Conklin, Victor Hogan, et al.
Journal of Bioenergetics and Biomembranes|February 24, 2007
Galectin-3 in apoptosis, a novel therapeutic targetPratima Nangia-Makker, Susumu Nakahara, Victor Hogan, et al.
The Journal of Biological Chemistry|October 22, 2022
Chimeric galectin-3 and collagens: Biomarkers and potential therapeutic targets in fibroproliferative diseasesPratima Nangia-Makker, Victor Hogan, Vitaly Balan, et al.
Pageof 6